24 results for: Biotechnology and Medical Research
Photograph
Joseph Ashley of ProCyte in lab, August 14, 1990
Founded in 1986 by Dr. Loren Pickart, ProCyte Corporation was a biotech medical skin company, which sold skincare products directly to dermatologists, include Iamin gel for wound dressing. Based in Kirkland, the company was acquired by Philadelphia-based PhotoMedex in 2005.Joseph Ashley, who had been president of the early Seattle biotech company Genetic Systems, served as President and CEO of ProCyte…
ID Number:2000.107.009.31.04
Date:1990
Photograph
Bruce Carter in Zymogenetics lab, Seattle, May 11, 1993
ZymoGenetics was established in Seattle in 1981 by University of Washington professors Earl Davie and Benjamin Hall, along with University of British Columbia professor Michael Smith. The company was acquired by Novo Nordisk in 1988, but spun off again as a separate public company in 2000, and was acquired again by Bristol-Myers Squibb in 2010. In 1993, the company moved…
ID Number:2000.107.032.33.01
Date:1993
Photograph
Cell Therapeutics technician at work in lab, October 6, 1992
Cell Therapeutics, Inc. (CTI) incorporated in September 1991 as part of Seattle's biotech boom. Using the motto "Making Cancer More Treatable," James A. Bianco, Jack Singer, and George Todaro, who met working at Fred Hutchinson Cancer Institute, spearheaded the company's work to improve cancer treatment drugs. With headquarters next to the Olympic Sculpture Park on the Seattle waterfront, the company…
ID Number:2000.107.033.30.01
Date:1992
Photograph
Steve Duzan of Immunex, February 1984
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.053.02.01
Date:1984
Photograph
Steve Duzan and Michael Kranda of Immunex, February 15, 1991
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.053.02.03
Date:1991
Photograph
Women working at Genetic Systems lab, Redmond, July 15, 1991
In 1980, New York stockbroker David Blech and his brother Isaac partnered with Dr. Robert Nowinski of the Fred Hutchinson Cancer Research Center in Seattle to start Genetic Systems, focused on producing antibodies to diagnose diseases. The Blech brothers raised $40 million in start-up costs, and the company went public in 1981. Bristol-Myers Squibb acquired the company, Seattle's first major…
ID Number:2000.107.073.47.01
Date:1991
Photograph
Dr. William Hutchinson at Fred Hutchinson Cancer Research Center, Seattle, March 1982
Dr. William Hutchinson (1909-1997) was a cancer surgeon and the founder of the Fred Hutchinson Cancer Research Center in Seattle. Hutchinson believed that research rather than surgery would ultimately provide the answer to fighting cancer, and he fought to establish a cancer research center in Seattle. In 1956, he helped found the Pacific Northwest Research Foundation, which studied cancer, heart…
ID Number:2000.107.095.02.01
Date:1982
Photograph
Bruce Mosley working on gene cloning at Immunex, Seattle, October 11, 1983
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.03
Date:1983
Photograph
Dace Krasts working in lab at Immunex, Seattle, July 23, 1992
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.04
Date:1992
Photograph
Noel Balantac working in lab at Immunex, Seattle, December 12, 1989
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.05
Date:1989